Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
572 PYX-102, an anti-KLRG1 antibody, enhances cytotoxic activity of CD8-T-cells from PBMC and human tumor samples by blocking the interaction between KLRG1 and cadherins
Compose a Response to This Article
Other responses
No responses have been published for this article.